AMGN | GILD | MRK | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 85 | 81 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | 9 Undervalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 8 | 11 | 29 | |
SMR RATING 1..100 | 14 | 96 | 79 | |
PRICE GROWTH RATING 1..100 | 22 | 31 | 39 | |
P/E GROWTH RATING 1..100 | 27 | 71 | 2 | |
SEASONALITY SCORE 1..100 | 85 | 13 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMGN's Valuation (8) in the Biotechnology industry is in the same range as GILD (9) in the Biotechnology industry, and is in the same range as MRK (11) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to GILD’s and similarly to MRK’s over the last 12 months.
AMGN's Profit vs Risk Rating (8) in the Biotechnology industry is in the same range as GILD (11) in the Biotechnology industry, and is in the same range as MRK (29) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to GILD’s and similarly to MRK’s over the last 12 months.
AMGN's SMR Rating (14) in the Biotechnology industry is somewhat better than the same rating for MRK (79) in the Pharmaceuticals Major industry, and is significantly better than the same rating for GILD (96) in the Biotechnology industry. This means that AMGN's stock grew somewhat faster than MRK’s and significantly faster than GILD’s over the last 12 months.
AMGN's Price Growth Rating (22) in the Biotechnology industry is in the same range as GILD (31) in the Biotechnology industry, and is in the same range as MRK (39) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to GILD’s and similarly to MRK’s over the last 12 months.
MRK's P/E Growth Rating (2) in the Pharmaceuticals Major industry is in the same range as AMGN (27) in the Biotechnology industry, and is significantly better than the same rating for GILD (71) in the Biotechnology industry. This means that MRK's stock grew similarly to AMGN’s and significantly faster than GILD’s over the last 12 months.
| AMGN | GILD | MRK | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 67% | 4 days ago 61% | N/A |
| Stochastic ODDS (%) | 1 day ago 55% | 1 day ago 62% | 1 day ago 65% |
| Momentum ODDS (%) | 1 day ago 61% | 1 day ago 61% | 1 day ago 55% |
| MACD ODDS (%) | 1 day ago 69% | 1 day ago 48% | 4 days ago 56% |
| TrendWeek ODDS (%) | 1 day ago 63% | 1 day ago 63% | 1 day ago 57% |
| TrendMonth ODDS (%) | 1 day ago 60% | 1 day ago 64% | 1 day ago 42% |
| Advances ODDS (%) | 12 days ago 61% | 1 day ago 64% | 4 days ago 57% |
| Declines ODDS (%) | 5 days ago 47% | 5 days ago 48% | 10 days ago 51% |
| BollingerBands ODDS (%) | 3 days ago 66% | 1 day ago 70% | 1 day ago 63% |
| Aroon ODDS (%) | 1 day ago 52% | 1 day ago 60% | 5 days ago 62% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMGN’s FA Score shows that 5 FA rating(s) are green while GILD’s FA Score has 3 green FA rating(s), and MRK’s FA Score reflects 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMGN’s TA Score shows that 8 TA indicator(s) are bullish while GILD’s TA Score has 5 bullish TA indicator(s), and MRK’s TA Score reflects 5 bullish TA indicator(s).
AMGN (@Pharmaceuticals: Major) experienced а +2.94% price change this week, while GILD (@Pharmaceuticals: Major) price change was +4.44% , and MRK (@Pharmaceuticals: Major) price fluctuated +0.90% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.53%. For the same industry, the average monthly price growth was -5.20%, and the average quarterly price growth was +5.33%.
AMGN is expected to report earnings on Nov 03, 2026.
GILD is expected to report earnings on Oct 22, 2026.
MRK is expected to report earnings on Oct 29, 2026.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.
| Ticker / NAME | Correlation To AMGN | 1D Price Change % | ||
|---|---|---|---|---|
| AMGN | 100% | +1.82% | ||
| PFE - AMGN | 51% Loosely correlated | +1.65% | ||
| GILD - AMGN | 48% Loosely correlated | +2.77% | ||
| ABBV - AMGN | 48% Loosely correlated | +1.49% | ||
| BIIB - AMGN | 47% Loosely correlated | +3.33% | ||
| MRK - AMGN | 47% Loosely correlated | +2.26% | ||
More | ||||